Literature DB >> 17869530

Production and separation of non-carrier-added 86Y from enriched 86Sr targets.

Miguel A Avila-Rodriguez1, Jonathon A Nye, Robert J Nickles.   

Abstract

The metallic radionuclide (86)Y was produced by irradiation of enriched (86)SrCO(3) on a low-energy proton-only cyclotron. Irradiations up to 20 microA for 2h were performed with 11 MeV protons using a water-cooled target mounting with circulating chilled helium. Experimental thick target yields of 26.7 mCi/microA yielded 24 mCi of (86)Y in 2h of bombardment at 10 microA. The difference in solubility products between Y(OH)(3) and Sr(OH)(2) allows the separation of (86)Y from an alkaline strontium solution by using filter paper with an overall yield of 88 +/- 3%. The concentration of Sr in the final product was found to be on the order of 15 ppm when using 200mg of target material as determined by ICP-MS analysis. The reactivity of (86)Y was determined to be on the order of 1.5 +/- 0.8 Ci/micromol of DOTA. The enriched target material was recovered and converted to its original chemical form with an overall efficiency >90%.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17869530     DOI: 10.1016/j.apradiso.2007.07.027

Source DB:  PubMed          Journal:  Appl Radiat Isot        ISSN: 0969-8043            Impact factor:   1.513


  13 in total

1.  Cyclotron produced ⁴⁴gSc from natural calcium.

Authors:  G W Severin; J W Engle; H F Valdovinos; T E Barnhart; R J Nickles
Journal:  Appl Radiat Isot       Date:  2012-05-24       Impact factor: 1.513

2.  A practical guide to the construction of radiometallated bioconjugates for positron emission tomography.

Authors:  Brian M Zeglis; Jason S Lewis
Journal:  Dalton Trans       Date:  2011-03-25       Impact factor: 4.390

3.  86/90Y-Based Theranostics Targeting Angiogenesis in a Murine Breast Cancer Model.

Authors:  Emily B Ehlerding; Carolina A Ferreira; Eduardo Aluicio-Sarduy; Dawei Jiang; Hye Jin Lee; Charles P Theuer; Jonathan W Engle; Weibo Cai
Journal:  Mol Pharm       Date:  2018-05-30       Impact factor: 4.939

Review 4.  86Y based PET radiopharmaceuticals: radiochemistry and biological applications.

Authors:  Tapan K Nayak; Martin W Brechbiel
Journal:  Med Chem       Date:  2011-09       Impact factor: 2.745

Review 5.  Expanding the PET radioisotope universe utilizing solid targets on small medical cyclotrons.

Authors:  K J H George; S Borjian; M C Cross; J W Hicks; P Schaffer; M S Kovacs
Journal:  RSC Adv       Date:  2021-09-21       Impact factor: 4.036

6.  Fatty acid-conjugated radiopharmaceuticals for fibroblast activation protein-targeted radiotherapy.

Authors:  Pu Zhang; Mengxin Xu; Jie Ding; Junyi Chen; Taiping Zhang; Li Huo; Zhibo Liu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-11-08       Impact factor: 10.057

7.  Albumin Binder-Conjugated Fibroblast Activation Protein Inhibitor Radiopharmaceuticals for Cancer Therapy.

Authors:  Mengxin Xu; Pu Zhang; Jie Ding; Junyi Chen; Li Huo; Zhibo Liu
Journal:  J Nucl Med       Date:  2021-09-30       Impact factor: 11.082

8.  ImmunoPET: Concept, Design, and Applications.

Authors:  Weijun Wei; Zachary T Rosenkrans; Jianjun Liu; Gang Huang; Quan-Yong Luo; Weibo Cai
Journal:  Chem Rev       Date:  2020-03-23       Impact factor: 60.622

Review 9.  PET radiometals for antibody labeling.

Authors:  Eduardo Aluicio-Sarduy; Paul A Ellison; Todd E Barnhart; Weibo Cai; Robert Jerry Nickles; Jonathan W Engle
Journal:  J Labelled Comp Radiopharm       Date:  2018-03-12       Impact factor: 1.921

Review 10.  Production of novel diagnostic radionuclides in small medical cyclotrons.

Authors:  Mateusz Adam Synowiecki; Lars Rutger Perk; J Frank W Nijsen
Journal:  EJNMMI Radiopharm Chem       Date:  2018-02-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.